Literature DB >> 1415226

Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I.

Z P Zhang1, M Lindstedt, G Falk, M Blombäck, N Egberg, M Anvret.   

Abstract

von Willebrand disease (vWD) is the most common inherited bleeding disorder in humans. The disease is caused by qualitative and quantitative abnormalities of the von Willebrand factor (vWF). Genomic DNA from 25 patients with vWD type III, the most severe form of the disease, was studied using PCR followed by restriction-enzyme analysis and direct sequencing of the products. Nonsense mutations (CGA----TGA) were detected in exons 28, 32, and 45 by screening of all the 11 CGA arginine codons of the vWF gene. Two patients were found to be homozygous and five heterozygous for the mutation. Both parents and some of the relatives of the homozygous patients carry the mutation. These are the first reported examples of homozygous point mutations associated with the severe form of vWD. In the three heterozygous probands, one of the parents carried the mutation and had vWD type I. Family studies including parents and family members with or without vWD type I indicated that these three heterozygous patients are likely to be compound heterozygous. Twenty-one individuals from these seven families with vWD type I were found to be heterozygous for the mutation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415226      PMCID: PMC1682774     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  On the characterization of acquired inhibitors to ristocetin induced platelet aggregation found in patients with von Willebrand's disease.

Authors:  N Egberg; M Blombäck
Journal:  Thromb Res       Date:  1976-11       Impact factor: 3.944

2.  Identification of a new nonsense mutation in the von Willebrand factor gene in patients with von Willebrand disease type III.

Authors:  Z P Zhang; G Falk; M Blombäck; N Egberg; M Anvret
Journal:  Hum Mol Genet       Date:  1992-04       Impact factor: 6.150

3.  On laboratory problems in diagnosing mild von Willebrand's disease.

Authors:  M Blombäck; P Eneroth; O Andersson; M Anvret
Journal:  Am J Hematol       Date:  1992-06       Impact factor: 10.047

Review 4.  The varieties of von Willebrand's disease.

Authors:  E G Tuddenham
Journal:  Clin Lab Haematol       Date:  1984

5.  Gene deletions correlate with the development of alloantibodies in von Willebrand disease.

Authors:  B B Shelton-Inloes; F F Chehab; P M Mannucci; A B Federici; J E Sadler
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

6.  Structure of the gene for human von Willebrand factor.

Authors:  D J Mancuso; E A Tuley; L A Westfield; N K Worrall; B B Shelton-Inloes; J M Sorace; Y G Alevy; J E Sadler
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

7.  Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity.

Authors:  M Anvret; M Blombäck; M Lindstedt; E Söderlind; M Tapper-Persson; A C Thelander
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

Review 8.  von Willebrand factor and von Willebrand disease.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

9.  Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease.

Authors:  K Y Ngo; V T Glotz; J A Koziol; D C Lynch; J Gitschier; P Ranieri; N Ciavarella; Z M Ruggeri; T S Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

10.  Mutagenic deamination of cytosine residues in DNA.

Authors:  B K Duncan; J H Miller
Journal:  Nature       Date:  1980-10-09       Impact factor: 49.962

View more
  10 in total

1.  Linkage disequilibrium patterns vary with chromosomal location: a case study from the von Willebrand factor region.

Authors:  W S Watkins; R Zenger; E O'Brien; D Nyman; A W Eriksson; M Renlund; L B Jorde
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

2.  Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence.

Authors:  J C Eikenboom; T Vink; E Briët; J J Sixma; P H Reitsma
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

Review 3.  Alloantibodies in von Willebrand disease.

Authors:  Paula D James; David Lillicrap; Pier M Mannucci
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

4.  Effects of the mutant von Willebrand factor gene in von Willebrand disease.

Authors:  Z Zhang; M Lindstedt; M Blombäck; M Anvret
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

5.  Mutations of von Willebrand factor gene in families with von Willebrand disease in the Aland Islands.

Authors:  Z P Zhang; M Blombäck; D Nyman; M Anvret
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.

Authors:  M Bowman; A Tuttle; C Notley; C Brown; S Tinlin; M Deforest; J Leggo; V S Blanchette; D Lillicrap; P James
Journal:  J Thromb Haemost       Date:  2013-03       Impact factor: 5.824

7.  Genetic heterogeneity of severe von Willebrand disease type III in the German population.

Authors:  R Schneppenheim; S Krey; F Bergmann; D Bock; U Budde; M Lange; R Linde; U Mittler; E Meili; G Mertes
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

8.  Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients.

Authors:  Priyanka Kasatkar; Shrimati Shetty; Kanjaksha Ghosh
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

9.  The role of exon 45 and 16 in the pathogenesis of Von Willebrand disease in Iranian Patients.

Authors:  M Nasiri; H Galehdari; M Darbouy; M Yavarian; B Keikhaee
Journal:  Iran J Ped Hematol Oncol       Date:  2012-09-22

10.  Discovery of Type 3 von Willebrand Disease in a Cohort of Patients with Suspected Hemophilia A in Côte d'Ivoire.

Authors:  Adia E Adjambri; Sylvie Bouvier; Roseline N'guessan; Emma N'draman-Donou; Mireille Yayo-Ayé; Marie-France Meledje; Missa L Adjé; Duni Sawadogo
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-03-01       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.